Dengue fever in China: An emerging problem demands attention

Emerging Microbes and Infections

Volumn 4, Issue 1, 2015, Pages e3-

  Jin, Xia ^a   Lee, Min ^a   Shu, Jiayi ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; CHLORPHENOTANE; CREATININE; DENGUE VACCINE; INSECT REPELLENT; RAIN;

AEDES AEGYPTI; AEDES ALBOPICTUS; AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ASCITES; AUTOIMMUNITY; BED NET; BLEEDING; CHINA; COMPLEMENT ACTIVATION; CREATININE BLOOD LEVEL; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENVIRONMENTAL SANITATION; ENVIRONMENTAL TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEVER; GALLBLADDER DISEASE; HUMAN; HYPOALBUMINEMIA; LETHARGY; LETTER; LEUKOPENIA; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; RASH; SHOCK; THROMBOCYTOPENIA; ANIMAL; COMMUNICABLE DISEASES, EMERGING; DENGUE VIRUS; DISEASE CARRIER; DISEASE OUTBREAKS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MOSQUITO; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VIROLOGY;

ANIMALS; CHINA; COMMUNICABLE DISEASES, EMERGING; CULICIDAE; DENGUE; DENGUE VACCINES; DENGUE VIRUS; DISEASE OUTBREAKS; HUMANS; INSECT VECTORS; MOSQUITO CONTROL;

EID: 84931268324     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2015.3     Document Type: Letter

References (14)

1. Chinese Center for Disease Control and Prevention. Reportable infectious disease statistics. Beijing: CCDC, 2014. Available at http://www.chinacdc.cn/tjsj/fdcrbbg/ (accessed 25 November 2014).
2. Guangdong Hygienic Birth Control Committee. Dengue fever cases update. Guangzhou: GCDC, 2014. Available at http://www.gdwst.gov.cn/a/yiqingxx/ (accessed 25 November 2014).
3. Marston HD, Folkers GK, Morens DM, Fauci AS. Emerging viral diseases: confronting threats with new technologies. Sci Transl Med 2014; 6: 253ps10.
4. Bhatt S, Gething PW, Brady OJ et al. The global distribution and burden of dengue. Nature 2013; 496: 504-507.
5. Normile D. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science 2013; 342: 415.
6. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: WHO, 2009. Available at whqlibdoc.who.int/publications/2009/9789241547871-eng.pdf/ (accessed 3 October 2014).
7. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239: 476-481.
8. Guzman MG, Harris E. Dengue. Lancet 2014; 19 September 2014. DOI: 10.1016/S0140-6736(14)60572-9.
9. Wills BA, Nguyen MD, Ha TL et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353: 877-889.
10. Commission of the European Communities. Regulation (EC) No 850/2004 of the European Parliament and of the Council on persistent organic pollutants and amending Directive 79/117/EEC. Brussels: EU, 2004. Available at http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52006PC0242&from=EN (accessed 3 October 2014).
11. Hoffmann AA, Montgomery BL, Popovici J et al. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 2011; 476: 454-457.
12. Walker T, Johnson PH, Moreira LA et al. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 2011; 476: 450-453.
13. Sabchareon A, Wallace D, Sirivichayakul C et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012; 380: 1559-1567.
14. Capeding MR, Tran NH, Hadinegoro SR et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014; 384: 1358-1365.